ASSESSING THE RISK FOR AUTOIMMUNE DISORDERS FOLLOWING USE OF THE QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINE: THE ONTARIO GRADE 8 HPV VACCINE COHORT STUDY
Introduction: In 2007 Ontario implemented a grade 8 quadrivalent human papillomavirus (qHPV) vaccination program targeting the virus that causes cervical cancer. Despite being 6 years post-implementation, few post-licensure studies have assessed the safety of the qHPV vaccine in this adolescent popu...
Main Author: | |
---|---|
Other Authors: | |
Language: | en en |
Published: |
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/1974/12071 |